Psilocybin-Assisted Psychotherapy

Tryp Therapeutics Announces Interim Results for Its Phase II Clinical Trial for the Treatment of Binge Eating Disorder With Psilocybin-Assisted Psychotherapy

Interim data analysis supports the potential effectiveness of psilocybin-assisted psychotherapy for the…

KELOWNA, BC / ACCESSWIRE / January 3, 2023 /Tryp Therapeutics, Inc. (CSE:TRYP)…

Ryan has been a financial writer for more than a decade, covering…

VANCOUVER, British Columbia, Oct. 03, 2024 (GLOBE NEWSWIRE) — Stallion Uranium…

Sometimes, inadequate systems and processes become so ingrained that a major catalyst…

The lithium market has had a bit of a rocky year, with…

Toronto, Ontario–(Newsfile Corp. – September 24, 2024) – Cardiol…